Hillel’s Tech Corner: MeMed: Bringing data to medicine

It is 2020 and we have self-driving cars, autonomous drones, and advanced robotics. Yet, when you go to the doctor with a headache, the ability to differentiate between a viral and bacterial infection is significantly harder than it should be. The result is often the prescription of antibiotics that are not actually needed.Antibiotic misuse contributes to the rise of antimicrobial resistance, which causes 700,000 deaths annually worldwide, a figure that is projected to increase to 10 million by 2050. By giving patients antibiotics they don’t need, more harm is being done than good. The ability to analyze data and extract deep and actionable insights into the nature and severity of a patient’s condition is imperative.Meet MeMed, an Israeli company founded in 2009, now with more than 70 employees, and offices in Haifa, Israel and the US.MeMed raised $100M+ from leading VCs and insurers, and is the recipient of $35M+ in
Read More